Pharmayat
ActiveSummary
The computed 12-month bankruptcy probability of Pharmayat is 3.2% (moderate). The 2024 annual accounts show equity of €30,022 and a net result of €27,855. Its solvency ranks better than 64% of 25,567 sector peers (NACE 47, financial year 2024). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Directors
1 director, no change since 2024
TATAÏAT Sohaïb
CurrentDirector · since 21-10-2024
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
1 person since 2024, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| TATAÏAT Sohaïb |
|
Owners and capital
Capital and shareholders
Shareholders according to the deeds
At incorporation
act of 21-10-2024 ↗
- TATAÏAT Sohaïb 100 shares (100%) · €3,000 in cash
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
Capital over the years
- 21-10-2024 Incorporation · €3,000 · 100 shares